Home / Auditor changes / Regen BioPharma Inc
Filed 2026-07-15 路 Form 8-K 路 Accession 0001493152-26-033364 nano
Price before filing: $0.0001 (2026-07-14 close, split/dividend-adjusted)
Market cap at flag: $28,666 (2026-07-15) 路 Latest: $61,556 (2026-10-16)
| Window | RGBP | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +0.0% | +3.3% | -3.3% | 2026-08-14 |
| 90 days | +100.0% | +3.7% | +96.3% | 2026-10-13 |
| 180 days | pending | pending | until 2027-01-11 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: no open-market insider sales or purchases reported.
30 days after: none reported.
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-04-16 to 2026-08-14. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: changed
Disagreements reported: no
Why this score: also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.